Literature DB >> 20226298

Cost-effectiveness of school-based asthma screening in an urban setting.

Joe K Gerald1, Roni Grad, William C Bailey, Lynn B Gerald.   

Abstract

BACKGROUND: Much has been done to promote population-based childhood asthma screening; however, concerns remain regarding its cost-effectiveness.
OBJECTIVES: To conduct a cost-effectiveness analysis of school-based asthma screening strategies.
METHODS: A 5 health state Markov approach (symptom-free, symptom, exacerbation recovery, emergency department, and hospitalization day) was used to evaluate school-based screening in a simulated population of urban elementary-age school children. Two questionnaire and 2 multistage strategies incorporating spirometry or spirometry with exercise testing were evaluated from the societal perspective by using 365 daily cycles. The outcome was 2006 dollars per quality-adjusted life year (QALY).
RESULTS: The most efficient strategy identified children with previously diagnosed but poorly controlled asthma at a cost of $150,000 per QALY (95% CI, $65,800-$318,000). Uncertainty surrounding the cost-effectiveness estimate was primarily a result of the symptom day preference weight estimate (44%), the probability of confirmation after screening (17%), the adequacy of asthma control in the population (9%), and the estimated treatment effect on symptoms (6%). Screening generated an additional 21 symptom-free day equivalents per child identified with previously diagnosed but not well controlled asthma and led to $85.55, $12.36, and $2.58 in additional screening, daily treatment, and indirect costs and $5.01 less in emergency department and hospitalization costs.
CONCLUSION: Population-based asthma screening is not cost-effective at $50,000 per QALY and has only a 20% chance of being cost-effective at $100,000 per QALY. The most efficient approach is to screen for previously diagnosed but poorly controlled asthma. Linking screening with better treatment, and long-term adherence strategies might yield future cost-effective approaches.

Entities:  

Mesh:

Year:  2010        PMID: 20226298     DOI: 10.1016/j.jaci.2009.12.984

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  3 in total

1.  The National Heart, Lung, and Blood Institute Strategic Vision Implementation for Health Equity Research.

Authors:  George A Mensah; Catherine M Stoney; Michelle M Freemer; Sharon Smith; Michael M Engelgau; W Keith Hoots; James P Kiley; David C Goff
Journal:  Ethn Dis       Date:  2019-02-21       Impact factor: 1.847

Review 2.  Advances in pediatric asthma in 2010: addressing the major issues.

Authors:  Stanley J Szefler
Journal:  J Allergy Clin Immunol       Date:  2011-01       Impact factor: 10.793

3.  An Economic Evaluation of Australia's Newborn Hearing Screening Program: A Within-Study Cost-Effectiveness Analysis.

Authors:  Rajan Sharma; Yuanyuan Gu; Kompal Sinha; Teresa Y C Ching; Vivienne Marnane; Lisa Gold; Melissa Wake; Jing Wang; Bonny Parkinson
Journal:  Ear Hear       Date:  2022 May/Jun       Impact factor: 3.562

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.